Cornerstone Planning Group LLC

Position in ARGX — Argenx SE

CIK 1822587 FAIRFIELD, NJ

Position in ARGX

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$10,953

-$1,661 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cornerstone Planning Group LLC holds $285,266 across 38 Biotechnology names. ARGX ranks #8 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	116	$51,798
2	ALNY	Alnylam Pharmaceuticals, Inc.	100	$33,087
3	REGN	Regeneron Pharmaceuticals, Inc.	35	$27,042
4	RPRX	Royalty Pharma plc	402	$19,283
5	RVMD	Revolution Medicines, Inc.	194	$18,866
6	HALO	Halozyme Therapeutics, Inc.	287	$18,548
7	CRSP	CRISPR Therapeutics AG	300	$14,271
8	ARGX	Argenx SE This page	15	$10,953

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,953	15	0.0%	Shares	Sole	2026-05-06
2025-12-31	$12,614	15	+7.1%	Shares	Sole	2026-02-02
2025-09-30	$10,325	14	0.0%	Shares	Sole	2025-11-04
2025-06-30	$7,717	14	-48.1%	Shares	Sole	2025-08-11
2025-03-31	$15,980	27	+28.6%	Shares	Sole	2025-04-30
2024-12-31	$12,915	21	-4.5%	Shares	Sole	2025-01-29
2024-09-30	$11,925	22	-26.7%	Shares	Sole	2024-11-05
2024-06-30	$12,901	30	-25.0%	Shares	Sole	2024-08-13
2024-03-31	$15,748	40	+14.3%	Shares	Sole	2024-05-07
2023-12-31	$13,315	35	+2.9%	Shares	Sole	2024-02-12
2023-09-30	$16,715	34	+6.2%	Shares	Sole	2023-11-08
2023-06-30	$12,471	32	—	Shares	Sole	2023-08-15
No filing history on record for this holder in this stock.